WHO ICTRP trial
Lipid Treatment Assessment Project2
NL-OMON29733 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON29733 |
|---|---|
| Public title | Lipid Treatment Assessment Project2 |
| Scientific title | Lipid Treatment Assessment Project2 - NRA5090005/ L-TAP2 |
| Primary sponsor | Pfizer |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | dyslipidemia; increased cholesterol;10011082;10052547;dyslipidemia; increased cholesterol |
| Interventions | ;Dyslipidemia;lipid managment;Treated |
| Registration date | Jan 17, 2007 |
| Target size | 1000 |
| Secondary IDs | NL13214.015.06 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: